PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-165.00%
Negative net income growth while BTE stands at 280.86%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
No Data
No Data available this quarter, please select a different quarter.
-102.63%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-318.18%
Both reduce yoy usage, with BTE at -316.22%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-23.40%
AR is negative yoy while BTE is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-160.78%
Both reduce yoy usage, with BTE at -316.22%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
15.37%
Some yoy increase while BTE is negative at -17.52%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-14.41%
Both yoy CFO lines are negative, with BTE at -8.01%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-20.53%
Both yoy lines negative, with BTE at -92.04%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-378.62%
Negative yoy acquisition while BTE stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
205.71%
Growth well above BTE's 254.90%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-66.05%
Both yoy lines negative, with BTE at -20.11%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
115.49%
Debt repayment above 1.5x BTE's 32.77%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.